Clinical Trial: A Study of Efficacy, Safety, and Tolerability of KAN-101 in People with Celiac Disease
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Celiac Disease
Study Type: INTERVENTIONAL
Official Title: A Phase 2a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of KAN-101 in Participants with Celiac Disease
Brief Summary:
The study goal is to evaluate the efficacy, safety, and tolerability of KAN-101 in participants with Celiac Disease (CeD)
Read more